ACETYLCYSTEINE AUROVITAS 200 mg ORAL SOLUTION GRANULES IN SACHETS
How to use ACETYLCYSTEINE AUROVITAS 200 mg ORAL SOLUTION GRANULES IN SACHETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet:information for the user
Acetylcysteine Aurovitas 200 mg granules for oral solution in sachets EFG
Read all of this leaflet carefully before you start taking this medicine,because it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only, and you should not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
Contents of the package leaflet
- What is Acetylcysteine Aurovitas and what is it used for
- What you need to know before you take Acetylcysteine Aurovitas
- How to take Acetylcysteine Aurovitas
- Possible side effects
5 Storage of Acetylcysteine Aurovitas
- Contents of the pack and further information
1. What is Acetylcysteine Aurovitas and what is it used for
Acetylcysteine Aurovitas contains the active substance acetylcysteine, which acts by dissolving the thick, viscous mucus of the respiratory tract.
This medicine is indicated in adults and adolescents over 12 years of age as an adjunct for the treatment of acute respiratory conditions associated with excessive mucus in the lungs and respiratory tract, when the mucus is too thick and viscous to cough up easily.
2. What you need to know before you take Acetylcysteine Aurovitas
Do not take Acetylcysteine Aurovitas
if you are/allergic
- allergicto acetylcysteine or to any of the other ingredients of this medicine (listed in section 6).
- Children under 2 years of age should not use this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before taking acetylcysteine.
- Changes in skin and mucous membranes.
If new changes occur in the skin and mucous membranes, you should consult a doctor immediately and stop using acetylcysteine.
- Bronchial asthma.
- Past or present stomach or intestinal ulcers.
- Hypersensitivity to histamine.
Long-term treatment should be avoided in these patients, as this medicine influences histamine metabolism and may cause intolerance symptoms (e.g. headache, nasal discharge, itching).
- Inability to expectorate mucus
- Acetylcysteine may increase the intensity of vomiting.
Children
Acetylcysteine is not recommended in children under 12 years of age (due to the high content of active ingredient).
Other medicines and Acetylcysteine Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This applies particularly to:
- Cough suppressants
The combined use of acetylcysteine with cough suppressants may cause a dangerous accumulation of secretion due to the reduction of the cough reflex. A particularly careful diagnosis is required for this combination therapy. It is essential that you ask your doctor before using this combination.
- Antibiotics
Experimental studies show evidence of a weakening effect of antibiotics (tetracyclines, aminoglycosides, penicillins) due to acetylcysteine. For safety reasons, antibiotics should be taken separately and with an interval of at least 2 hours.
- Activated charcoal
- Glyceryl trinitrate: a medicine also known as nitroglycerin, used to dilate blood vessels.
Your doctor will monitor if you have low blood pressure, which could be severe and could be detected by headache.
- Carbamazepine
The combination of acetylcysteine and carbamazepine (a medicine for epilepsy) may reduce the therapeutic effect of carbamazepine.
- It is not recommended to use acetylcysteine, in solution, with other medicines.
- Acetylcysteine may interfere with heavy metal salts, such as gold and iron salts, and with calcium salts. Therefore, it is best to separate the intake of acetylcysteine and these salts or administer them by another route.
Laboratory tests
Tell your doctor that you are taking acetylcysteine if you need a test for:
it may affect the determination of:
- salicylates:medicines for treating pain, inflammation, or rheumatism.
- ketone bodies in urine.
Pregnancy,breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Since there is not enough experience with the use of this medicine in pregnant women, it is recommended that, as a precautionary measure, acetylcysteine should not be used during pregnancy. You should use acetylcysteine during pregnancy only if your doctor considers it absolutely necessary.
Breast-feeding
There is no information available on the excretion of acetylcysteine in breast milk. Therefore, you should use this medicine during breast-feeding only if your doctor considers it absolutely necessary.
Fertility
There are limited data on the influence of acetylcysteine on fertility in humans. Animal studies do not show effects on human fertility at the recommended doses.
Driving and using machines
The influence on the ability to drive and use machines is not known.
Acetylcysteine Aurovitascontains sucrose
This medicine contains 0.66 g of sucrose per dose (0.66 g sucrose/1 sachet).
If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Acetylcysteine Aurovitas contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per sachet; this is, essentially “sodium-free”.
3. How to take Acetylcysteine Aurovitas
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose, unless your doctor prescribes otherwise, is:
Adults and adolescents over 12 years of age:
Take 200 mg (1 sachet) of acetylcysteine every 8 hours, 3 times a day. Do not take more than 600 mg/day.
Use in children:
Do not use in children under 12 years of age.
There are other formulations that are more suitable for this population.
Method of administration
This medicine can be taken with or without food.
Dissolve the granulated contents of one sachet in half a glass of water or other liquid and mix until it becomes a homogeneous solution. Use a glass or plastic cup (never use a rubber or metal cup). Partially used sachets can be stored until the next intake (it is recommended to use the other half within 24 hours). However, solutions should be used immediately.
Take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Consult your doctor or pharmacist if you are not sure.
When opening the sachet, there may be a slight smell of sulfur (rotten eggs). This is a normal characteristic of this medicine and does not mean it is not safe to use.
Duration of treatment
If your symptoms worsen or do not improve after 5 days, you should consult your doctor.
If you take moreAcetylcysteine Aurovitasthan you should
In case of overdose, stomach and intestinal irritation may occur, such as abdominal pain, nausea, vomiting, diarrhea.
To date, no serious side effects or symptoms of intoxication have been observed, even in the case of massive overdose. However, if an overdose with acetylcysteine is suspected, please inform your doctor.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Acetylcysteine Aurovitas
Do not take a double dose to make up for forgotten doses. Simply take your next dose at the usual time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking this medicine and contact your doctor if you get signs of an allergic reaction or a severe skin reaction.
Uncommon(may affect up to 1 in 100 people)
- Allergic reactions.
Rare(may affect up to 1 in 10,000 people)
- Severe allergic reactionssuch as skin rash, itching, fluid accumulation (edema), breathing difficulties, and loss of consciousness.
Other possible side effects may occur with the following frequencies:
Uncommon(may affect up to 1 in 100 people)
- Headache.
- Fever.
- Inflammation of the inner lining of the mouth.
- Abdominal pain.
- Nausea, vomiting.
- Diarrhea.
- Ringing or buzzing in the ears.
- Fast heart rate.
- Low blood pressure.
- Itching, hives, skin rash.
- Severe, mostly painful, inflammation of the deep layers of the skin, mainly on the face.
Rare(may affect up to 1 in 1,000 people)
- Breathing difficulties.
- Bronchospasm.
- Indigestion.
Very rare(may affect up to 1 in 10,000 people)
- Bleeding.
- Dizziness.
Frequency not known(frequency cannot be estimated from the available data)
- Inflammation of the tissue in the face caused by excess fluid.
- Reduction of platelet accumulation in the blood.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Acetylcysteine Aurovitas
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the sachet and carton after “EXP”. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
6. Contents of the pack and further information
Composition of Acetylcysteine Aurovitas
- The active substance is acetylcysteine.
Each sachet contains 200 mg of acetylcysteine.
- The other ingredients (excipients) are: sucrose, sodium saccharin, orange flavor (corn syrup, natural and artificial flavorings, gum arabic).
Appearance and packaging of the product
Granules for oral solution in sachets.
White to off-white granular powder packaged in sachets.
Sizes of packaging:
14, 18, 20, 24, 30, and 60 sachets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
O
Generis Farmacêutica, S.A.
Rua João de Deus, 19
2700-487 Amadora
Portugal
O
Arrow Generiques
26 Avenue Tony Garnier,
Lyon 69007
France
This medicine is authorised in the Member States of the European Economic Area under the following names:
Belgium: Acetylcysteine AB 200 mg granules for oral solution in sachet/granulés pour solution buvable en sachet/ Granulat zur Herstellung einer Lösung zum Einnehmen im Beutel
Spain: Acetilcisteína Aurovitas 200 mg granulado para solución oral en sobres EFG
France: ACETYLCYSTEINE ARROW 200 mg, granulés pour solution buvable en sachet
Italy: Nakys
Portugal: Acetilcisteína Generis
Date of last revision of this leaflet: June 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
- Country of registration
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to ACETYLCYSTEINE AUROVITAS 200 mg ORAL SOLUTION GRANULES IN SACHETSDosage form: EFFERVESCENT TABLET, 600 mgActive substance: acetylcysteineManufacturer: Kern Pharma S.L.Prescription not requiredDosage form: EFFERVESCENT TABLET, 600 mgActive substance: acetylcysteineManufacturer: Laboratorios Alter S.A.Prescription requiredDosage form: EFFERVESCENT TABLET, 200 mgActive substance: acetylcysteineManufacturer: Aurovitas Spain, S.A.U.Prescription required
Online doctors for ACETYLCYSTEINE AUROVITAS 200 mg ORAL SOLUTION GRANULES IN SACHETS
Discuss questions about ACETYLCYSTEINE AUROVITAS 200 mg ORAL SOLUTION GRANULES IN SACHETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
